Gotham Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5M | Buy |
91,129
+60,106
| +194% | +$7.55M | 0.07% | 427 |
|
|
2025
Q1 | $3.43M | Buy |
31,023
+25,309
| +443% | +$2.8M | 0.03% | 634 |
|
|
2024
Q4 | $780K | Sell |
5,714
-9,603
| -63% | -$1.31M | 0.01% | 988 |
|
|
2024
Q3 | $1.76M | Sell |
15,317
-22,962
| -60% | -$2.65M | 0.02% | 760 |
|
|
2024
Q2 | $5.27M | Buy |
38,279
+32,975
| +622% | +$4.54M | 0.07% | 413 |
|
|
2024
Q1 | $732K | Sell |
5,304
-234
| -4% | -$32.3K | 0.01% | 935 |
|
|
2023
Q4 | $730K | Buy |
5,538
+480
| +9% | +$63.2K | 0.01% | 875 |
|
|
2023
Q3 | $569K | Sell |
5,058
-355
| -7% | -$39.9K | 0.01% | 940 |
|
|
2023
Q2 | $510K | Sell |
5,413
-2,180
| -29% | -$206K | 0.01% | 963 |
|
|
2023
Q1 | $769K | Sell |
7,593
-236
| -3% | -$23.9K | 0.02% | 822 |
|
|
2022
Q4 | $935K | Buy |
7,829
+2,204
| +39% | +$263K | 0.03% | 703 |
|
|
2022
Q3 | $597K | Buy |
5,625
+29
| +0.5% | +$3.08K | 0.02% | 810 |
|
|
2022
Q2 | $545K | Sell |
5,596
-1,427
| -20% | -$139K | 0.02% | 759 |
|
|
2022
Q1 | $658K | Buy |
7,023
+4,465
| +175% | +$418K | 0.02% | 706 |
|
|
2021
Q4 | $218K | Buy |
+2,558
| New | +$218K | 0.01% | 1055 |
|
|
2020
Q4 | – | Sell |
-18,712
| Closed | -$1.8M | – | 1069 |
|
|
2020
Q3 | $1.8M | Buy |
18,712
+5,870
| +46% | +$564K | 0.06% | 386 |
|
|
2020
Q2 | $1.57M | Sell |
12,842
-6,363
| -33% | -$776K | 0.05% | 457 |
|
|
2020
Q1 | $1.66M | Sell |
19,205
-10,460
| -35% | -$905K | 0.05% | 445 |
|
|
2019
Q4 | $3.19M | Buy |
29,665
+15,730
| +113% | +$1.69M | 0.06% | 366 |
|
|
2019
Q3 | $1.26M | Buy |
13,935
+3,431
| +33% | +$309K | 0.02% | 540 |
|
|
2019
Q2 | $887K | Sell |
10,504
-8,828
| -46% | -$745K | 0.01% | 658 |
|
|
2019
Q1 | $1.7M | Buy |
19,332
+2,956
| +18% | +$260K | 0.02% | 525 |
|
|
2018
Q4 | $1.17M | Sell |
16,376
-7,246
| -31% | -$517K | 0.02% | 601 |
|
|
2018
Q3 | $2.9M | Buy |
23,622
+16,209
| +219% | +$1.99M | 0.04% | 438 |
|
|
2018
Q2 | $728K | Buy |
+7,413
| New | +$728K | 0.01% | 631 |
|